GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Avarept® | compound 1 [WO2024071349] | SJP-0132 | SJP0132
motugivatrep is an approved drug
Compound class:
Synthetic organic
Comment: Motugivatrep (SJP-0132) is a selective transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonist [3]. It was designed to ameliorate the signs and symptoms dry eye disease.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| We have been unable to find quantitative data to support antagonist activity at the drug's primary molecular target. |